These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7125982)

  • 1. Effects of anticholinergic drugs on memory in Parkinson's disease.
    Sadeh M; Braham J; Modan M
    Arch Neurol; 1982 Oct; 39(10):666-7. PubMed ID: 7125982
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective analysis of the effects of anticholinergic medication on memory performance in Parkinson's disease.
    Levin BE; Llabre MM; Reisman S; Weiner WJ; Brown MC
    J Neuropsychiatry Clin Neurosci; 1991; 3(4):412-6. PubMed ID: 1821262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.
    Horrocks PM; Vicary DJ; Rees JE; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):936-41. PubMed ID: 4772727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term memory in Parkinson's disease after withdrawal of long-term anticholinergic therapy.
    van Herwaarden G; Berger HJ; Horstink MW
    Clin Neuropharmacol; 1993 Oct; 16(5):438-43. PubMed ID: 8221704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudo-obstruction secondary to anticholinergic drugs in Parkinson's disease.
    Howard LM; Markus H
    Postgrad Med J; 1992 Jan; 68(795):70-1. PubMed ID: 1561204
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
    Dubois B; Pilon B; Lhermitte F; Agid Y
    Ann Neurol; 1990 Aug; 28(2):117-21. PubMed ID: 2221841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confusion, dementia and anticholinergics in Parkinson's disease.
    de Smet Y; Ruberg M; Serdaru M; Dubois B; Lhermitte F; Agid Y
    J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1161-4. PubMed ID: 7161613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental impairment in Parkinson's disease. The role of anticholinergic drugs.
    Meco G; Casacchia M; Lazzari R; Franzese A; Castellana F; Carta A; Iannuccelli M; Agnoli A
    Acta Psychiatr Belg; 1984; 84(4):325-35. PubMed ID: 6507124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic dementia in Parkinson disease treated by long-term administration of anticholinergic drug--evaluation of neuropsychological test, PET, and SPECT].
    Nishiyama K; Mizuno T; Sakuta M; Kurisaki H; Momose T
    Rinsho Shinkeigaku; 1991 Jun; 31(6):625-31. PubMed ID: 1934777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition memory in Parkinson's disease.
    Flowers KA; Pearce I; Pearce JM
    J Neurol Neurosurg Psychiatry; 1984 Nov; 47(11):1174-81. PubMed ID: 6502175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anticholinergics on memory in Parkinson's disease.
    Syndulko K; Tourtellotte WW
    Arch Neurol; 1983 Jun; 40(6):390. PubMed ID: 6847450
    [No Abstract]   [Full Text] [Related]  

  • 12. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease.
    Hauser RA; Olanow CW
    Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticholinergic treatment of Parkinson's disease (author's transl)].
    Ascher PW
    Wien Klin Wochenschr; 1976 Oct; 88(19):641-6. PubMed ID: 790774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
    Cooper JA; Sagar HJ; Doherty SM; Jordan N; Tidswell P; Sullivan EV
    Brain; 1992 Dec; 115 ( Pt 6)():1701-25. PubMed ID: 1486457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dyskinesia induced by anticholinergic drugs--electrophysiological analysis].
    Mano T
    Rinsho Shinkeigaku; 1974 Mar; 14(3):255-65. PubMed ID: 4153837
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinson's disease.
    Wolters EC; Calne DB
    CMAJ; 1989 Mar; 140(5):507-14. PubMed ID: 2563667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prescription of anticholinergic agents in the elderly. Potential dangers to be well aware of].
    Dubois B
    Rev Prat; 1992 Nov; 42(17):2207-9. PubMed ID: 1290044
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of anticholinergic drugs on 123I-IMP SPECT in Parkinson's disease].
    Mizuno T; Nishiyama K; Hitoshi S; Takeda K; Sakuta M
    Rinsho Shinkeigaku; 1992 Apr; 32(4):375-80. PubMed ID: 1395322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia, memory, and anticholinergic drugs.
    Frith CD
    J Abnorm Psychol; 1984 Aug; 93(3):339-41. PubMed ID: 6470319
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for cognitive toxicity of anticholinergic drugs.
    Katz IR; Greenberg WM; Barr GA; Garbarino C; Buckley P; Smith D
    J Clin Psychiatry; 1985 Aug; 46(8):323-6. PubMed ID: 2862135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.